Late-Onset Blau Syndrome: A Case of Misdiagnosis, Delayed Diagnosis, and the Impact of Social Challenges
Year: 2025
Type: article
Study design: Case Report
Abstract: Blau syndrome is a rare, autosomal dominant, autoinflammatory disease caused by mutations in the NOD2 gene, characterized by arthritis, dermatitis, and uveitis. Symptoms typically appear in early childhood, before age 4, and later presentation is uncommon. We present a patient with late-onset Blau syndrome, with symptom onset at age 10 and diagnosis at age 18. At age 10, our patient developed a severe, refractory generalized rash initially diagnosed as eczema, along with eye redness and irritation initially diagnosed as allergic conjunctivitis. These diagnoses were not challenged due to inconsistent follow-up. The rash was complicated by multiple superimposed skin infections leading to scarring. Our patient was an excellent athlete, but at age 14, he developed thoracic back pain, hip and wrist arthritis, and malformations, including prominent bending of the fifth fingers and toes, which hindered physical activity. The family suspected undiagnosed food allergies, leading to food withholding and resulting in protein deficiency over three years. A skin biopsy, planned several times, was delayed due to family hesitancy but was finally performed at age 16, revealing granulomatous dermatitis. At the same time, he was experiencing chronic diarrhea and bloating, but colonoscopy was never completed due to intolerance of the preparation. Although his symptoms were concerning for inflammatory bowel disease, diagnostic pathology was never obtained for this reason. However, an upper endoscopy revealed H. Pylori gastritis and changes suggestive of celiac disease, including blunted villi. Pathology demonstrated chronic duodenopathy. At age 18, he was referred to allergy and immunology, where genetic testing confirmed a pathogenic NOD2 mutation, diagnosing Blau syndrome. Other laboratory findings included low IgM (33), elevated IgE, but normal IgG and IgA, and fluctuating CRP. QuantiFERON was negative. A unique aspect of this patient’s case is the delayed onset and the significant impact of social determinants of health on the patient’s care. Since diagnosis, consistent in-person follow-up has been difficult to arrange due to frequently missed appointments for unknown reasons. This case highlights the challenges of diagnosing late-onset Blau syndrome in the setting of inconclusive laboratory evaluation and underscores the role of social factors in medical management.
Source: Journal of Human Immunity
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4409786166